‘Researchers found that a combination of filter
paper and mesh - originally a net curtain from John Lewis - was the best way to
create a 3D environment for cells that resembled native tissue,' said
Rosemary Drake, Chief Scientific Officer at TAP Biosystems, a pioneer in the
field of tissue regeneration.
The
Hertfordshire company is commercialising fundamental research carried out by
Professor Robert Brown and Professor Julie Daniels of University College London
into how to mimic the biological processes involved in growing
tissue.
TAP
Biosystems has developed a process called Rapid Automated Fabrication of
Tissues (RAFT), which among other areas of research is being applied at
Moorfields Eye Hospital in an effort to regenerate the surface of damaged
corneas, the transparent part of the eye that covers the
pupil.
A
preclinical trial of the process involving stem cells are underway at the
hospital and will be completed in 2015. The trial is being supported with
£526k after the project won a development therapeutics competition in the
Technology Strategy Board's regenerative medicine
programme.
The
Technology Strategy Board is our best friend
The
bulk of the early development of the corneal treatment, which took place
between August 2008 and December 2011, was funded by a £1.27m grant
awarded to TAP
Biosystems and University College London after they won a
Technology Strategy Board cell therapy competition. The partners received
additional funding from the Technology Strategy Board for two more projects for
other aspects of the research.
The
Technology Strategy Board's support also resulted in a spin-off product:
TAP Biosystems subsequently developed a range of kits for researchers and
pharmaceutical companies based on RAFT aimed at a vast worldwide market for 3D
cell culture products.
‘I spotted the potential for turning Professor
Brown's work into a tool for researching into cell biology, at a time when
no one else seemed very interested in the work,' said
Rosemary.
‘With Technology Strategy Board funding to kick
start the project, I persuaded our board to invest very significant sums of
money in the project.
‘The Technology Strategy Board is our best friend.
The funding has been transformative, allowing us to take a much more long term
view of what is a very high risk development that has been going since August
2008.
Click
Here for Full Press Release